In this issue of the Bridge, we have an exclusive interview with Liu Xuan, Managing Director of Belimed. Belimed is a leading provider of cleaning and sterilization equipment to hospitals. Mr. Liu shares his view in regard to the Covid-19 impact and the look ahead for his company and industry.
In addition, we have conducted several interviews to cover the broader range of the Swiss medtech industry. Our editor Fabian Gull reached out to Susi Wang of the Swiss Business Hub in Beijing, Daniel Bont of Switzerland Global Enterprise and Dirk Reuter of Sigvaris and the Swiss Medtech Association.
In an interesting article, Yvan Sprünglin, General Manager of SICPA China, is explaining how companies can successfully fight against counterfeit goods and how to avoid fraud and revenue losses.
We also publish a new assessment by InterChina Consulting, which looked at the decoupling trends in China based on a survey with over 200 companies.
We hope you enjoy reading this issue of the Bridge.
The Free Trade Agreement between Switzerland and China came into effect in July 2014.
A lot has changed since we published our first edition of the Development Zone Directory back in 2017. But China remains one of the top investment hotspots in the world, despite ongoing trade and other disputes the country faces. While it is true that companies and countries are relocating or building up additional supply chains to lessen their dependence on China, it is also a fact that no other country has the industrial capacity, growing middle class and growth potential.